Original Research
Accepted on 23 Dec 2024
Eosinophil is a Predictor of Severe Immune-Related Adverse Events Induced by Ipilimumab plus Nivolumab Therapy in Patients with Renal Cell Carcinoma: A Retrospective
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Dec 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Dec 2024
in Nutrition and Metabolism
Original Research
Accepted on 23 Dec 2024
in Human Factors and Digital Health
Systematic Review
Accepted on 23 Dec 2024
in Networks and Communications
Original Research
Accepted on 23 Dec 2024
in Structural Materials
Original Research
Accepted on 23 Dec 2024
in Microbial Physiology and Metabolism
Original Research
Accepted on 23 Dec 2024
in Electrochemistry
Original Research
Accepted on 23 Dec 2024
in Marine Fisheries, Aquaculture and Living Resources
Original Research
Accepted on 23 Dec 2024
in Semiconducting Materials and Devices
Original Research
Accepted on 23 Dec 2024
in Geoinformatics
Original Research
Accepted on 23 Dec 2024
in Biomechanics
Review
Accepted on 23 Dec 2024
in Food Allergy
Original Research
Accepted on 23 Dec 2024
in Integrative Bioinformatics
Original Research
Accepted on 23 Dec 2024
in Ocean Observation
Original Research
Accepted on 23 Dec 2024
in Human Factors and Digital Health
Systematic Review
Accepted on 23 Dec 2024
in Public Health Education and Promotion